ArticleCureus2025
Successful Management of Intractable Hiccups in Diabetic Ketoacidosis: A Case Report on the Efficacy of Inhaled Nebulized Lidocaine.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intractable hiccups are a rare but distressing symptom that can significantly impair a patient's quality of life, particularly in those with underlying medical conditions such as diabetic ketoacidosis (DKA). This case report describes a 59-year-old male patient with a history of type 2 diabetes mellitus and hypertension who presented to the emergency department with persistent hiccups lasting for five days, coinciding with an exacerbation of his diabetes leading to DKA. Despite initial treatments with metoclopramide, chlorpromazine, and baclofen, the hiccups persisted, causing considerable distress. The patient was subsequently treated with inhaled nebulized lidocaine at a dosage of 150 mg daily for two days. Remarkably, within 24 hours, the patient experienced a significant reduction in hiccup frequency, and by the end of the treatment course, the hiccups had completely resolved. This case highlights the potential efficacy of nebulized lidocaine as an alternative treatment for intractable hiccups associated with DKA, particularly when conventional therapies fail. Given the promising results, further research is warranted to explore the mechanisms and broader applicability of this treatment approach in similar patient populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.